4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-030184
Chief Medical Officer sold 2,000 shares at an average $85.00 ($170,003)
- Chief Medical Officer acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bowden Christopher Chief Medical Officer | 2018-05-11 | Option exercise | +2,000 | $35.16 | $70,320 | 2,881 | D |
| Bowden Christopher Chief Medical Officer | 2018-05-11 | Sale | −840 | $84.81 | $71,240 | 2,041 | D |
| Bowden Christopher Chief Medical Officer | 2018-05-11 | Sale | −1,160 | $85.14 | $98,762 | 881 | D |
| Derivatives | |||||||
| Bowden Christopher Chief Medical Officer | 2018-05-11 | Option exercise · Stock option (right to buy) | −2,000 | 97,000 | D | ||
| Open-market sales · 2,000 sh · avg $85.00 · $170,003 | |||||||
Loading xslF345X03/doc4.xml…